Oral presentation: New insights and therapeutically strategies for emphysema and COPD: the growth factors KGF and TGF?-1

A. Ö. Yildirim, M. Vandana, G. John, B. Müller, H. Fehrenbach (Borstel, Germany)

Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Number: 5
Disease area: Airway diseases

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ö. Yildirim, M. Vandana, G. John, B. Müller, H. Fehrenbach (Borstel, Germany). Oral presentation: New insights and therapeutically strategies for emphysema and COPD: the growth factors KGF and TGF?-1. Lung Science Conference 2010 - Biology of gene-environment interactions in the lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC 2010 Abstract: New insights and therapeutically strategies for emphysema and COPD: The growth factors KGF and TGFβ-1
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010

Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016

Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016

Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009


Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009



Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
Source: Eur Respir J 2014; 44: 513-522
Year: 2014



Airway inflammation in asthma: current and future targets and therapies
Source: Breathe 2010; 6: 245-252
Year: 2010

Translating mechanisms to new drugs for COPD exacerbations
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009


Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007


New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008